Nkarta NKTX
NASDAQ NKTX
$1.74 -0.01 (-0.57%)
At close: Oct 22, 2026 · 4:00 PM EDT

Nkarta (NKTX) EBIT Margin (2019)

Updated

Nkarta (NKTX) posted EBIT Margin of -19433.91% for FY2019.

Analysis

Nkarta (NKTX) EBIT Margin (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 24.35%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 37.86%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 20.57%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 34.95%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -133.21%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 28.37%
10 Nkarta 124.63 Mn -1.56 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 -202,375.30%
API Access

Nkarta EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=NKTX&period=max&api_key=YOUR_API_KEY